Predicting residual cholesteatoma with the Potsic staging system still lacks evidence: a systematic review and meta-analysis
Open Access
- 13 February 2024
- journal article
- review article
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 281 (7) , 3557-3568
Abstract
Purpose: To investigate the rate of residual disease in the Potsic staging system for congenital cholesteatomas. Methods: A protocol registration was published on PROSPERO (CRD42022383932), describing residual disease as a primary outcome and hearing improvement as secondary. A systematic search was performed in four databases (PubMed, Embase, Cochrane Library, Web of Science) on December 14, 2022. Articles were included if cholesteatomas were staged according to the Potsic system and follow-up duration was documented. Risk of bias was evaluated using the Quality In Prognosis Studies (QUIPS) tool. In the statistical synthesis a random effects model was used. Between-study heterogeneity was assessed using I2. Results: Thirteen articles were found to be eligible for systematic review and seven were included in the meta-analysis section. All records were retrospective cohort studies with high risk of bias. Regarding the proportions of residual disease, analysis using the χ2 test showed no statistically significant difference between Potsic stages after a follow-up of minimum one year (stage I 0.06 (confidence interval (CI) 0.01–0.33); stage II 0.20 (CI 0.09–0.38); stage III 0.06 (CI 0.00–0.61); stage IV: 0.17 (CI 0.01–0.81)). Postoperative and preoperative hearing outcomes could not be analyzed due to varied reporting. Results on cholesteatoma location and mean age at staging were consistent with those previously published. Conclusion: No statistically significant difference was found in the proportions of residual disease between Potsic stages, thus the staging system’s applicability for outcome prediction could not be proven based on the available data. Targeted studies are needed for a higher level of evidence.Keywords
Funding Information
- Semmelweis University
This publication has 33 references indexed in Scilit:
- Efficacy and Safety of Transcanal Endoscopic Ear Surgery for Congenital CholesteatomasOtology & Neurotology, 2015
- Clinical features, presenting symptoms, and surgical results of congenital cholesteatoma based on Potsic's staging systemActa Oto-Laryngologica, 2014
- Surgical outcomes of early congenital cholesteatoma: Minimally invasive transcanal approachThe Laryngoscope, 2013
- Congenital CholesteatomaPredictors for Residual Disease and Hearing OutcomesJAMA Otolaryngology–Head & Neck Surgery, 2012
- Congenital Middle Ear Cholesteatoma in Children; Retrospective Review of 35 CasesJournal of Korean Medical Science, 2009
- Congenital Cholesteatoma: Theories, Facts, and 53 PatientsOtolaryngologic Clinics of North America, 2006
- Improved tests for a random effects meta‐regression with a single covariateStatistics in Medicine, 2003
- Congenital CholesteatomaJAMA Otolaryngology–Head & Neck Surgery, 2002
- Committee on Hearing and Equilibrium Guidelines for the Evaluation of Results of Treatment of Conductive Hearing Loss∗Otolaryngology–Head and Neck Surgery, 1995
- Chronic suppurative otitis mediaThe Pediatric Infectious Disease Journal, 1988